News

Leadership Transition at NATROX® Wound Care

Inotec AMD, the leading innovator in Continuous Topical Oxygen Therapy (cTOT) for advanced wound care and parent company of NATROX Wound Care, announces a leadership transition. After seven years of dedicated service, Craig Kennedy has accepted another role in the industry and will be stepping down as CEO. With this transition, Gordie Nye will assume the role of CEO while continuing as Chairman of the Inotec AMD Board.

Read More
NATROX® Wound Care Announces Vice President of U.S. Sales & Global Marketing

March 21, 2025
VA Grants 5-year Extension to FSS Contract for NATROX® O₂ Continuous Topical Oxygen Therapy (cTOT)

January 30, 2025
Inotec AMD appoints Gordie Nye as Chairman of the Board

January 20, 2025
As part of LER Magazine’s (Lower Extremity Review) 15th anniversary celebration, they asked readers to weigh in on the many facets of innovation that have helped improve patient outcomes in lower extremity care.

January 07, 2025
Inotec AMD Appoints Stefanie Brown Hawkins as CFO to Drive Strategic Growth and Innovation

December 16, 2024
Inotec Secures $33 Million in Series C Financing to Accelerate US Expansion

December 02, 2024
WHS Grants ‘Level I’ Recommendation to Topical Oxygen Therapy

December 13, 2023
New Expert Consensus: Topical Oxygen Therapy in Wound Healing

August 18, 2023
NATROX® O₂ Now Available in South Korea

August 17, 2023